Guided Therapeutics (GTHP) Current Deferred Revenue (2019 - 2026)
Guided Therapeutics' Current Deferred Revenue came in at $189,000 for Q2 2026, down 72.2% from $679,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Guided Therapeutics (GTHP) Current Deferred Revenue (2019 - 2026) Analysis & Trends
Going back to Q3 2019, Guided Therapeutics' Current Deferred Revenue data covers 28 quarters.
- Current Deferred Revenue carries a five-year compound annual growth rate of 35.1% (FY2020 to FY2025).
- Going back by year, Current Deferred Revenue was $849,000 in FY2024 (+100.2%), $424,000 in FY2023 (-16.7%), $509,000 in FY2022 (+51.0%) and $337,000 in FY2021 (+702.4%).
- The five-year range for quarterly Current Deferred Revenue is $189,000 (Q4 2025) to $849,000 (Q4 2024).
- Year-over-year, Current Deferred Revenue has declined for six consecutive quarters, with an average decline of 10.4% over the last eight quarters.
- The fastest year-over-year change in Current Deferred Revenue over five years came in Q1 2022 (growth of 729.0%), and the weakest in Q4 2025 (a decline of 77.7%).
- Business Quant data shows GTHP's Current Deferred Revenue at $189,000 (Q1 2026), $189,000 (Q4 2025) and $689,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn |
| 10 | Guided Therapeutics | 24.13 Mn | 23.60 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 189,000.00 |
| Mar 31, 2026 | 189,000.00 |
| Dec 31, 2025 | 189,000.00 |
| Sep 30, 2025 | 689,000.00 |
| Jun 30, 2025 | 679,000.00 |
| Mar 31, 2025 | 670,000.00 |
| Dec 31, 2024 | 849,000.00 |
| Sep 30, 2024 | 748,000.00 |
| Jun 30, 2024 | 748,000.00 |
| Mar 31, 2024 | 748,000.00 |
| Dec 31, 2023 | 424,000.00 |
| Sep 30, 2023 | 451,000.00 |
| Jun 30, 2023 | 445,000.00 |
| Mar 31, 2023 | 488,000.00 |
| Dec 31, 2022 | 509,000.00 |
| Sep 30, 2022 | 509,000.00 |
| Jun 30, 2022 | 513,000.00 |
| Mar 31, 2022 | 514,000.00 |
| Dec 31, 2021 | 337,000.00 |
| Sep 30, 2021 | 278,000.00 |
API Access
Guided Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=GTHP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "GTHP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=GTHP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();